INHIBIKASE THERAPEUTICS INC

IKTNASDAQ

🏆 #2943 by market capEarnings Nov 13US Equity

$773.24▲ $31.39 (+4.06%)

Simulated price

1h—

24h▲ 4.1%

7d—

14d—

30d—

1y—

🏦Market Cap

$323M

Small Cap

📈Revenue Growth (YoY)

—

📊Gross Margin

—

💵FCF Margin

25.0%

Strong

⚖️P/S Ratio

1015.0x

Expensive

Otter Score

59

Weak

🔭

No analyst ratings for IKT

We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.